162 related articles for article (PubMed ID: 24944637)
1. Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis.
Masunaga SI; Sakurai Y; Tano K; Tanaka H; Suzuki M; Kondo N; Narabayashi M; Watanabe T; Nakagawa Y; Maruhashi A; Ono K
Exp Ther Med; 2014 Jul; 8(1):291-301. PubMed ID: 24944637
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of combination with both continuous administration of hypoxic cytotoxin and mild temperature hyperthermia in boron neutron capture therapy in terms of local tumor response and lung metastatic potential.
Masunaga SI; Sakurai Y; Tanaka H; Takata T; Suzuki M; Sanada Y; Tano K; Maruhashi A; Ono K
Int J Radiat Biol; 2019 Dec; 95(12):1708-1717. PubMed ID: 31545117
[No Abstract] [Full Text] [Related]
3. Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.
Masunaga S; Sakurai Y; Tanaka H; Suzuki M; Liu Y; Kondo N; Maruhashi A; Kinashi Y; Ono K
Br J Radiol; 2012 Mar; 85(1011):249-58. PubMed ID: 22391496
[TBL] [Abstract][Full Text] [Related]
4. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
Masunaga SI; Ono K; Kirihata M; Takagaki M; Sakurai Y; Kinashi Y; Kobayashi T; Nagasawa H; Uto Y; Hori H
Jpn J Cancer Res; 2001 Sep; 92(9):996-1007. PubMed ID: 11572769
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of mild temperature hyperthermia combined with a newly developed hypoxia-oriented 10B conjugate compound, TX-2100, for boron neutron capture therapy.
Masunaga S; Nagasawa H; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Int J Hyperthermia; 2006 Jun; 22(4):287-99. PubMed ID: 16754350
[TBL] [Abstract][Full Text] [Related]
7. Modification of the response of a quiescent cell population within a murine solid tumour to boron neutron capture irradiation: studies with nicotinamide and hyperthermia.
Masunaga S; Ono K; Suzuki M; Takagaki M; Sakurai Y; Kobayashi T; Akuta K; Akaboshi M; Kinashi Y; Abe M
Br J Radiol; 1997 Apr; 70(832):391-8. PubMed ID: 9166076
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.
Masunaga S; Ono K; Sakurai Y; Takagaki M; Kobayashi T; Kinashi Y; Suzuki M
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):828-39. PubMed ID: 11697329
[TBL] [Abstract][Full Text] [Related]
9. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
10. Reducing intratumour acute hypoxia through bevacizumab treatment, referring to the response of quiescent tumour cells and metastatic potential.
Masunaga S; Liu Y; Tanaka H; Sakurai Y; Suzuki M; Kondo N; Maruhashi A; Ono K
Br J Radiol; 2011 Dec; 84(1008):1131-8. PubMed ID: 21586505
[TBL] [Abstract][Full Text] [Related]
11. Significance of manipulating tumour hypoxia and radiation dose rate in terms of local tumour response and lung metastatic potential, referring to the response of quiescent cell populations.
Masunaga S; Matsumoto Y; Kashino G; Hirayama R; Liu Y; Tanaka H; Sakurai Y; Suzuki M; Kinashi Y; Maruhashi A; Ono K
Br J Radiol; 2010 Sep; 83(993):776-84. PubMed ID: 20739345
[TBL] [Abstract][Full Text] [Related]
12. Significance of manipulating intratumor hypoxia in the effect on lung metastases in radiotherapy, with reference to its effect on the sensitivity of intratumor quiescent cells.
Masunaga S; Matsumoto Y; Hirayama R; Kashino G; Tanaka H; Suzuki M; Kinashi Y; Liu Y; Ando K; Ono K
Clin Exp Metastasis; 2009; 26(7):693-700. PubMed ID: 19466568
[TBL] [Abstract][Full Text] [Related]
13. The impact of TP53 status of tumor cells including the type and the concentration of administered 10B delivery agents on compound biological effectiveness in boron neutron capture therapy.
Masunaga SI; Sanada Y; Takata T; Tanaka H; Sakurai Y; Suzuki M; Kirihata M; Ono K
J Radiat Res; 2023 Mar; 64(2):399-411. PubMed ID: 36763853
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of hypoxia-specific cytotoxic bioreductive agent-sodium borocaptate-10B conjugates as 10B-carriers in boron neutron capture therapy.
Masunaga S; Nagasawa H; Gotoh K; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Radiat Med; 2006 Feb; 24(2):98-107. PubMed ID: 16715670
[TBL] [Abstract][Full Text] [Related]
15. Potential of alpha-amino alcohol p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, regarding its enantiomers.
Masunaga S; Ono K; Kirihata M; Takagaki M; Sakurai Y; Kinashi Y; Kobayashi T; Suzuki M; Nagata K; Nagasawa H; Uto Y; Hori H
J Cancer Res Clin Oncol; 2003 Jan; 129(1):21-8. PubMed ID: 12618897
[TBL] [Abstract][Full Text] [Related]
16. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy.
Ono K; Masunaga SI; Kinashi Y; Takagaki M; Akaboshi M; Kobayashi T; Akuta K
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1081-6. PubMed ID: 8600091
[TBL] [Abstract][Full Text] [Related]
17. Alteration of sensitivity of intratumor quiescent and total cells to gamma-rays following thermal neutron irradiation with or without 10B-compound.
Masunaga S; Ono K; Suzuki M; Sakurai Y; Kobayashi T; Takagaki M; Kinashi Y; Akaboshi M
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):653-9. PubMed ID: 10701745
[TBL] [Abstract][Full Text] [Related]
18. Reoxygenation in quiescent and total intratumor cells following thermal neutron irradiation with or without (10)B-compound-compared with that after gamma-ray irradiation.
Masunaga S; Ono K; Suzuki M; Sakurai Y; Kobayashi T; Takagaki M; Kinashi Y; Akaboshi M
Int J Radiat Oncol Biol Phys; 1999 May; 44(2):391-8. PubMed ID: 10760435
[TBL] [Abstract][Full Text] [Related]
19. Applicability of combination with tirapazamine in boron neutron capture therapy.
Masunaga S; Ono K; Sakurai Y; Hori H; Kobayashi T; Takagaki M; Suzuki M; Kinashi Y; Akaboshi M
Jpn J Cancer Res; 1998 Jul; 89(7):768-74. PubMed ID: 9738984
[TBL] [Abstract][Full Text] [Related]
20. Significance of Fractionated Administration of Thalidomide Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis.
Masunaga SI; Sanada Y; Moriwaki T; Tano K; Sakurai Y; Tanaka H; Suzuki M; Kondo N; Narabayashi M; Watanabe T; Nakagawa Y; Maruhashi A; Ono K
World J Oncol; 2014 Aug; 5(4):155-165. PubMed ID: 29147396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
